Tengion - Dividend History | TNGNQ
Historical dividend payout and yield for Tengion (TNGNQ) since 1971. The current TTM dividend payout for Tengion (TNGNQ) as of December 31, 1969 is $0.00. The current dividend yield for Tengion as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
|
Tengion, Inc. is a clinical-stage biotechnology company, focused on discovering, developing, manufacturing and commercializing a range of replacement neo-organs and neo-tissues, currently derived from a patient's own (autologous) cells. The Company creates these functional neo-organs and neo-tissues using a patient's autologous cells, in conjunction with its Organ Regeneration Platform. Tengion's lead product candidate, the Neo-Urinary Conduit, is an autologous implant that catalyzes regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal, or cystectomy. Its product pipeline also includes various candidates in early stage development, such as Neo-Kidney Augment for patients with advanced chronic kidney disease, or CKD. The Company intends to develop our technology to address unmet medical needs in urologic, renal, gastrointestinal and vascular diseases. Tengion, Inc. is headquartered in East Norriton, Pennsylvania.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
